CD24 and cancer: In summary, while CD24-targeted immunotherapy holds promise in the treatment of cancer and non-neoplastic diseases, numerous questions related to its clinical application, efficacy, safety, and combination strategies still need to be addressed through rigorous research and clinical trials.